These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 26617314

  • 1. Enhanced delivery of Paclitaxel using electrostatically-conjugated Herceptin-bearing PEI/PLGA nanoparticles against HER-positive breast cancer cells.
    Yu K, Zhao J, Zhang Z, Gao Y, Zhou Y, Teng L, Li Y.
    Int J Pharm; 2016 Jan 30; 497(1-2):78-87. PubMed ID: 26617314
    [Abstract] [Full Text] [Related]

  • 2. The co-delivery of paclitaxel and Herceptin using cationic micellar nanoparticles.
    Lee AL, Wang Y, Cheng HY, Pervaiz S, Yang YY.
    Biomaterials; 2009 Feb 30; 30(5):919-27. PubMed ID: 19042015
    [Abstract] [Full Text] [Related]

  • 3. Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer.
    Wang S, Shao M, Zhong Z, Wang A, Cao J, Lu Y, Wang Y, Zhang J.
    Drug Deliv; 2017 Nov 30; 24(1):1791-1800. PubMed ID: 29172759
    [Abstract] [Full Text] [Related]

  • 4. Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer.
    Sun B, Ranganathan B, Feng SS.
    Biomaterials; 2008 Feb 30; 29(4):475-86. PubMed ID: 17953985
    [Abstract] [Full Text] [Related]

  • 5. PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells.
    Su WP, Cheng FY, Shieh DB, Yeh CS, Su WC.
    Int J Nanomedicine; 2012 Feb 30; 7():4269-83. PubMed ID: 22904633
    [Abstract] [Full Text] [Related]

  • 6. Comparison of three different conjugation strategies in the construction of herceptin-bearing paclitaxel-loaded nanoparticles.
    Yu K, Zhou Y, Li Y, Sun X, Sun F, Wang X, Mu H, Li J, Liu X, Teng L, Li Y.
    Biomater Sci; 2016 Aug 19; 4(8):1219-32. PubMed ID: 27367271
    [Abstract] [Full Text] [Related]

  • 7. Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy.
    Wang S, Zhang J, Wang Y, Chen M.
    Nanomedicine; 2016 Feb 19; 12(2):411-20. PubMed ID: 26711968
    [Abstract] [Full Text] [Related]

  • 8. Vitamin E-Oligo(methyl diglycol l-glutamate) as a Biocompatible and Functional Surfactant for Facile Preparation of Active Tumor-Targeting PLGA Nanoparticles.
    Wu J, Zhang J, Deng C, Meng F, Zhong Z.
    Biomacromolecules; 2016 Jul 11; 17(7):2367-74. PubMed ID: 27305935
    [Abstract] [Full Text] [Related]

  • 9. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin.
    Chen H, Xie LQ, Qin J, Jia Y, Cai X, Nan W, Yang W, Lv F, Zhang QQ.
    Colloids Surf B Biointerfaces; 2016 Feb 01; 138():1-9. PubMed ID: 26638176
    [Abstract] [Full Text] [Related]

  • 10. Development of innovative paclitaxel-loaded small PLGA nanoparticles: study of their antiproliferative activity and their molecular interactions on prostatic cancer cells.
    Le Broc-Ryckewaert D, Carpentier R, Lipka E, Daher S, Vaccher C, Betbeder D, Furman C.
    Int J Pharm; 2013 Oct 01; 454(2):712-9. PubMed ID: 23707251
    [Abstract] [Full Text] [Related]

  • 11. Functionalized nanoscale β-1,3-glucan to improve Her2+ breast cancer therapy: In vitro and in vivo study.
    Nasrollahi Z, Mohammadi SR, Mollarazi E, Yadegari MH, Hassan ZM, Talaei F, Dinarvand R, Akbari H, Atyabi F.
    J Control Release; 2015 Mar 28; 202():49-56. PubMed ID: 25597638
    [Abstract] [Full Text] [Related]

  • 12. Modulation of in vitro phagocytic uptake and immunogenicity potential of modified Herceptin®-conjugated PLGA-PEG nanoparticles for drug delivery.
    Badkas A, Frank E, Zhou Z, Jafari M, Chandra H, Sriram V, Lee JY, Yadav JS.
    Colloids Surf B Biointerfaces; 2018 Feb 01; 162():271-278. PubMed ID: 29216514
    [Abstract] [Full Text] [Related]

  • 13. Poly-(Lactic-co-Glycolic) Acid Nanoparticles for Synergistic Delivery of Epirubicin and Paclitaxel to Human Lung Cancer Cells.
    Sharma N, Kumari RM, Gupta N, Syed A, Bahkali AH, Nimesh S.
    Molecules; 2020 Sep 16; 25(18):. PubMed ID: 32947799
    [Abstract] [Full Text] [Related]

  • 14. Herceptin conjugated PLGA-PHis-PEG pH sensitive nanoparticles for targeted and controlled drug delivery.
    Zhou Z, Badkas A, Stevenson M, Lee JY, Leung YK.
    Int J Pharm; 2015 Jun 20; 487(1-2):81-90. PubMed ID: 25865568
    [Abstract] [Full Text] [Related]

  • 15. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y, Pan J, Feng SS.
    Int J Pharm; 2010 Aug 16; 395(1-2):243-50. PubMed ID: 20472049
    [Abstract] [Full Text] [Related]

  • 16. Polyethyleneimine/poly-(γ-glutamic acid)/poly(lactide-co-glycolide) nanoparticles for loading and releasing antiretroviral drug.
    Kuo YC, Yu HW.
    Colloids Surf B Biointerfaces; 2011 Nov 01; 88(1):158-64. PubMed ID: 21764569
    [Abstract] [Full Text] [Related]

  • 17. Herceptin-decorated salinomycin-loaded nanoparticles for breast tumor targeting.
    Aydın RS.
    J Biomed Mater Res A; 2013 May 01; 101(5):1405-15. PubMed ID: 23086911
    [Abstract] [Full Text] [Related]

  • 18. Photochemical internalization for pDNA transfection: evaluation of poly(d,l-lactide-co-glycolide) and poly(ethylenimine) nanoparticles.
    Gargouri M, Sapin A, Arıca-Yegin B, Merlin JL, Becuwe P, Maincent P.
    Int J Pharm; 2011 Jan 17; 403(1-2):276-84. PubMed ID: 21044878
    [Abstract] [Full Text] [Related]

  • 19. Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor.
    Yang R, Shim WS, Cui FD, Cheng G, Han X, Jin QR, Kim DD, Chung SJ, Shim CK.
    Int J Pharm; 2009 Apr 17; 371(1-2):142-7. PubMed ID: 19118614
    [Abstract] [Full Text] [Related]

  • 20. Herceptin-functionalized pure paclitaxel nanocrystals for enhanced delivery to HER2-postive breast cancer cells.
    Noh JK, Naeem M, Cao J, Lee EH, Kim MS, Jung Y, Yoo JW.
    Int J Pharm; 2016 Nov 20; 513(1-2):543-553. PubMed ID: 27686050
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.